Rice Partnership, LLC Amgen Inc Transaction History

Rice Partnership, LLC

$552 Million
Q2 2025

A detailed history of Rice Partnership, LLC transactions in Amgen Inc stock. As of the latest transaction made, Rice Partnership, LLC holds 1,525 shares of AMGN stock, worth $449,295. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,525

Previous 1,138 34.01%

Holding current value

$449,295

Previous $354,000 20.06%

% of portfolio

0.08%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$262.28 - $309.85 $101,502 - $119,911	387 Added 34.01%	1,525 $425,000
Q1 2025 Apr 29, 2025	SELL	$258.59 - $327.36 $6,206 - $7,856	-24 Reduced 2.07%	1,138 $354,000
Q4 2024 Jan 24, 2025	BUY	$258.78 - $328.31 $300,702 - $381,496	1,162 New	1,162 $302,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $233,921 - $274,067	-1,102 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$233.58 - $259.14 $39,475 - $43,794	-169 Reduced 13.3%	1,102 $269,000
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $2.55 Million - $2.97 Million	-11,495 Reduced 90.04%	1,271 $316,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $188,034 - $223,915	-869 Reduced 6.37%	12,766 $2.94 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $374,032 - $415,954	1,594 Added 13.24%	13,635 $3.47 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $295,923 - $363,139	1,496 Added 14.19%	12,041 $2.84 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $316,915 - $420,316	1,739 Added 19.75%	10,545 $2.14 Million
Q4 2019 Jan 30, 2020	BUY	$189.21 - $243.2 $308,412 - $396,416	1,630 Added 22.71%	8,806 $2.12 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $1.25 Million - $1.5 Million	7,176 New	7,176 $1.39 Million

Others Institutions Holding AMGN

# of Institutions

3,275

Shares Held

442M

Call Options Held

6.15M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Partnership, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Partnership, LLC with notifications on news.

Account

Rice Partnership, LLC Amgen Inc Transaction History